Nuvation Bio Inc. — Director's Dealing 2025

May 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2025-05-02

Reporting Person: Liu Dongfang (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-02	Class A Common Stock	M	20000	$1.94	Acquired	32000	Direct
2025-05-02	Class A Common Stock	S	20000	$2.5012	Disposed	12000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-02	Stock Option (Right to Buy)	$1.94	M	20000	Disposed	2033-02-27	Class A Common Stock (20000)	Direct

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan dated October 10, 2024.

F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.50 to $2.505. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: Option vests as to 25% on 2/28/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date